Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Frampas

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2011
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclideEric Frampas, Catherine Maurel, Patricia Remaud-Le Saëc, et al.
Cancer Immunology, Immunotherapy : CII|November 28, 2021
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumabMathilde Bureau, Thierry Chatellier, Tanguy Perennec, et al.
Cancer|February 4, 2010
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinomaPierre-Yves Salaun, Caroline Bodet-Milin, Eric Frampas, et al.
European Journal of Gastroenterology & Hepatology|February 10, 2011
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrenceCéline Deleau, Bruno Buecher, Caroline Rousseau, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
Frontiers in Pharmacology|April 16, 2015
A pretargeting system for tumor PET imaging and radioimmunotherapyFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Annals of Intensive Care|August 2, 2022
Infected pancreatic necrosis complicating severe acute pancreatitis in critically ill patients: predicting catheter drainage failure and need for necrosectomyCharlotte Garret, Marion Douillard, Arthur David, et al.
Journal of Clinical Lipidology|October 22, 2018
In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstructionFrançois Moreau, Claire Blanchard, Christophe Perret, et al.
Mycoses|April 22, 2017
Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016)Jessie Bourcier, Pierre-Marie Heudes, Florent Morio, et al.
International Journal of Molecular Sciences|February 14, 2015
Tumor immunotargeting using innovative radionuclidesFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|August 23, 2011
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclideEric Frampas, Catherine Maurel, Patricia Remaud-Le Saëc, et al.
Cancer Immunology, Immunotherapy : CII|November 28, 2021
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumabMathilde Bureau, Thierry Chatellier, Tanguy Perennec, et al.
Cancer|February 4, 2010
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinomaPierre-Yves Salaun, Caroline Bodet-Milin, Eric Frampas, et al.
European Journal of Gastroenterology & Hepatology|February 10, 2011
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrenceCéline Deleau, Bruno Buecher, Caroline Rousseau, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
Frontiers in Pharmacology|April 16, 2015
A pretargeting system for tumor PET imaging and radioimmunotherapyFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Annals of Intensive Care|August 2, 2022
Infected pancreatic necrosis complicating severe acute pancreatitis in critically ill patients: predicting catheter drainage failure and need for necrosectomyCharlotte Garret, Marion Douillard, Arthur David, et al.
Journal of Clinical Lipidology|October 22, 2018
In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstructionFrançois Moreau, Claire Blanchard, Christophe Perret, et al.
Mycoses|April 22, 2017
Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: Data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016)Jessie Bourcier, Pierre-Marie Heudes, Florent Morio, et al.
International Journal of Molecular Sciences|February 14, 2015
Tumor immunotargeting using innovative radionuclidesFrançoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Pageof 6